Bright Security Dynamic Application Security Testing vs ImmuniWeb® Neuron: 2026 Comparison

Bright Security Dynamic Application Security Testing

Mid-market and enterprise development teams need DAST that actually finds business logic flaws and API vulnerabilities without drowning in false positives, and Bright Security Dynamic Application Security Testing delivers both; its sub-3% false positive rate and dedicated detection for shadow APIs and LLM prompt injection mean your teams spend time fixing real issues instead of tuning rules. The platform's pull request automation and CI/CD integration also close the gap between findings and remediation that NIST ID.RA risk assessment requires. Skip this if your organization runs primarily monolithic applications on legacy infrastructure or needs on-premises deployment; Bright's strength is in modern API-first architectures.

ImmuniWeb® Neuron

Developers and security teams in SMB to mid-market organizations need fast, low-noise vulnerability scanning without the false-positive tax that kills adoption, and ImmuniWeb® Neuron's money-back zero false-positive SLA actually enforces accountability where competitors just claim accuracy. The AI-enhanced crawling and fuzzing catch OWASP Top 10 and API vulnerabilities across AWS, Azure, and GCP with risk-based scoring tied to working exploits, reducing the triage load your team actually faces. Skip this if you need integrated SAST or supply chain scanning; Neuron is narrowly focused on dynamic testing, which is exactly why it doesn't bloat your pipeline with unrelated findings.